Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Study data from Wayne State University update knowledge of bioengineering
August 26th, 2008
In this recent report, researchers in the United States conducted a study "To identify the antitumor activity and wound-healing effect of docetaxel delivered in the surgical tumor microenvironment of head and neck squamous cell carcinoma (HNSCC). Control and experimental series." "Academic medical center. BALB/c and severe combined immunodeficiency mice. Intrawound (IW) docetaxel therapy was tested in 3 HNSCC xenograft and 2 taxane-resistant models. Intratumoral (IT) docetaxel therapy was further tested in the 2 taxane-resistant models. Tumor size, survival, and wound toxic effects were measured. The effect of docetaxel on various factors involved in wound healing and...
Source: Cancer Weekly (2008-08-26)
|
